Business Wire

Identify3D Deploys Gemalto Solution to Ensure Protection of Its Customers’ IP and Manufacturing Data

Del

Gemalto, the world leader in digital security, today announced that Identify3D, the most advanced security solution for digital manufacturing supply chains, has deployed Gemalto’s SafeNet Data Protection On Demand to ensure the security of its customers’ intellectual property and quality of their digital manufacturing services in the cloud.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190311005361/en/

With customers in extremely security-conscious sectors such as aerospace and defence, it is critical that Identify3D builds strong data security controls into its cloud-based services in order to protect customers’ sensitive information and intellectual property. After looking at on-premises alternatives and cloud providers, Identify3D selected SafeNet Data Protection on Demand due to its ability to provide a wide range of cloud-based hardware security module (HSM), encryption, and key management services that easily integrate with the applications and cloud services it already uses.

“Identify3D provides intellectual property protection, manufacturing repeatability and traceability in all phases of digital manufacturing from unauthorized distribution, transformation, replication and production. Security is integral to everything we do,” said co-founder and Chief Strategy Officer Stephan Thomas. “For many companies operating in our space, security is only bolted on when customers ask for it. That’s not the way we do things; for us security, specifically data protection, must be a part of the process from day one. As our customers seek to expand their capabilities, we needed a solution that would enable them to grow comfortably, without compromising our security-first principles.”

With SafeNet Data Protection on Demand, Identify3D was able to deploy a cloud-based HSM service to act as the root of trust for its certificate authority and support advanced algorithms. The company is now able to offer its customers secure digital manufacturing services while enjoying the flexibility and scalability of a managed cloud-based security service with zero upfront investment.

"Identify3D can now provide our customers unrivalled protection of their valuable data and intellectual property, while verifying that their manufacturing is authorized and authenticated according to the exact standards. Within a couple of months of the solution being implemented, we saw a significant 35% cost saving and are able to add new clients quickly and efficiently in less than an hour,” added Thomas.

“Many cloud service providers want to lock you in and make you buy more services when you need to expand. Gemalto’s business model matched our requirements and the process was simple,” said Doug Peterson, Identify3D senior field application engineer. “Moving forward it will be much easier to upgrade customers to the cloud, move keys around, add new firmware, and support remotely. As our service provides multi-tier role separation access control between customers and different types of manufacturing within the same company, it is now simple to offer the service in a hosted service delivery model.”

Todd Moore, senior vice president, Data Protection at Gemalto said: “It’s refreshing to see another company that employs a security-first approach. For too long businesses have maintained a ‘buy now add security later’ mentality for their customers, which is putting too many end users at risk. With SafeNet Data Protection on Demand, Identify3D is able to efficiently provide a secure digital manufacturing service that meets the quality of service and data protection requirements of their customers.”

Additional Resources

About Identify3D

Identify3D Inc. de-risks digital manufacturing with a suite of solutions that protects the confidentiality and integrity of data throughout the digital manufacturing thread. Identify3D provides intellectual property protection, manufacturing repeatability and traceability — from initial design through to finished product. Identify3D delivers greater control over the digital manufacturing process, and ensures the integrity and authenticity of digital information across complex supply chains. The company is privately held and based in San Francisco. For more information, visit www.identify3d.com.

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2018 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.

From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.

Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.

Our 15,000 employees operate out of 110 offices, 47 personalization and data centers, and 35 research and software development centers located in 47 countries.

For more information visit www.gemalto.com, or follow @gemalto on Twitter.

Contact information

Gemalto media:
Tauri Cox
North America
+1 512 257 3916
tauri.cox@gemalto.com

Sophie Dombres
Europe Middle East & Africa
+33 4 42 36 57 38
sophie.dombres@gemalto.com

Jaslin Huang
Asia Pacific
+65 6317 3005
jaslin.huang@gemalto.com

Alexis Camarillo
Latin America
+52 5521223627
alexis.camarillo@gemalto.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Workiva Named Best-In-Class Cloud Service Provider at UK Cloud Awards17.5.2019 12:00:00 CESTPressemelding

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, was named the Best-In-Class Cloud Service Provider by the UK Cloud Awards 2019 at a ceremony here last night. Now in its sixth year, the UK Cloud Awards recognise innovation and excellence in the cloud industry by showcasing leading companies, customers and individuals in the United Kingdom. Workiva was recognised for its Wdesk platform that helps organisations consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders. Workiva, the global leader in XBRL and Inline XBRL, is also streamlining how customers comply with the European Securities and Markets Authority's mandate for Inline XBRL for European Single Electronic Format (ESEF) reporting. More than 5,000 EU issuers will be required to use ESEF taxonomy for their annual financial reports, ending on or after Jan

Novaremed Presents Top-Line Results from Phase 2a Diabetic Neuropathic Pain Study of NRD.E1 at NeuPSIG 201917.5.2019 10:13:00 CESTPressemelding

Novaremed AG, a clinical-stage Swiss biopharmaceutical company, today announced a poster presentation highlighting the top-line results from a Phase 2a (Proof of Concept) study of NRD.E1 for the treatment of diabetic neuropathic pain (DNP). The poster presentation took place at the 7th International Congress on Neuropathic Pain Meeting (NeuPSIG) in London, UK on May 9-11, 2019. “This was our first communication at a leading neuropathic pain-focused event. Novaremed’s lead drug, NRD.E1 is a non-opioid small molecule for the treatment of neuropathic pain. The results of our Phase 2a in patients with DNP showed clinically relevant treatment benefit from NRD.E1 across multiple primary and secondary endpoints, providing a strong scientific foundation for advancing the development of NRD.E1 into the upcoming global Phase 2b study in DNP,” said Sara Mangialaio, Head of R&D and Chief Medical Officer of Novaremed AG. “NRD.E1 has the potential to address a major unmet medical need in DNP.” Poste

WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology17.5.2019 09:38:00 CESTPressemelding

The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers in Paris (France) on June 23-24, 2019 to discuss Innovation and Global Deployment of Precision Oncology. The current status of Precision Oncology across the globe will be examined with the exceptional participation of the chairmen of the event, Richard L. Schilsky, Chairman WIN Consortium(*), Senior Vice-President and Chief Medical Officer of ASCO, and Josep Tabernero, Vice Chairman WIN Consortium, President of ESMO and Director of Vall d’Hebron Institute of Oncology, Spain. Global experience will be shared: Optimizing Patient Enrollment and Efficacy of Precision Oncology Clinical Trials at UT MD Anderson Cancer Center, USA Decision Support for Precision Oncology: Evolving from Monotherapy to Genomically Informed Combinations, UT MD Anderson Cancer Center, USA The Value of Personalized Medici

Corsearch Acquires Principium Trademark Watch and Domain Services Businesses17.5.2019 08:00:00 CESTPressemelding

Corsearch, the global brand creation, clearance, and protection leader, is pleased to announce the acquisition of the Principium Strategies trademark watch and domain services businesses, the brand protection subsidiary of Ladas and Parry LLP, a leader in global intellectual property law. The acquisition is effective immediately, solidifying and expanding Corsearch’s full-service trademark solutions offering for clients and brands globally. Principium is Corsearch’s third acquisition since becoming a standalone company in January 2018. The acquisition brings Corsearch’s employee count to more than 350 operating in 28 locations worldwide and adds valuable industry expertise and additional capabilities to Corsearch. “This is another really exciting acquisition for our business and a step forward in the evolution of Corsearch,” said Stephen Stolfi, Chief Commercial Officer of Corsearch. “Principium has provided clients with industry-leading trademark watching services for over 80 years an

CNT Among SAP’s "Best of the Best"17.5.2019 08:00:00 CESTPressemelding

Since 2005, SAP is honoring the best of the best SAP projects yearly in Europe, Middle East and Africa. In 2018, 280 customers from 15 markets submitted their regional Gold Award-winning projects. CNT Management Consulting from Vienna won Bronze twice – together with its customers HOERBIGER and TANNPAPIER – a happy day for CNT’s CEO Andreas Doerner. "We are now on the podium for the second time with two projects – thanks to the trust of our customers." The SAP Quality Awards EMEA were presented at an exceptionally festive ceremony in Heidelberg Castle (Baden-Wuerttemberg), and only twelve SAP customers were able to take home the most wanted trophies that were presented by SAP Presidents Brian Duffy (EMEA North) and Hartmut Thomsen (Middle and Eastern Europe). The jury evaluated the projects according to the ten SAP quality principles and the question of whether the respective project could fulfill the expectations of its clients. HOERBIGER - Category Business Transformation Headquarter

EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe17.5.2019 07:25:00 CESTPressemelding

EVER Pharma Holding Ges.m.b.H (Austria) announced today that it has completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals that operates the company's commercial operations in Germany. Amneal Deutschland already distributes several EVER Pharma products in Germany and is a strongly established player in the German hospital market. The acquired entity will be rebranded to EVER Pharma GmbH. “This acquisition represents another milestone in the expansion of EVER Pharma’s commercial footprint in Europe. With this new operation, EVER Pharma extends its portfolio in Germany and establishes a solid platform for the growth of its portfolio and pipeline” commented Georges Kahwati, General Manager of EVER Pharma. “We are pleased to establish another EVER affiliate in one of the key European markets in line with our strategy of establishing our own business presence in core markets.” added Julia Hillebrand, Managing Director and Owner. About EVER Pharma: EVER